A detailed history of Beacon Investment Advisory Services, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 753 shares of BIO stock, worth $246,584. This represents 0.01% of its overall portfolio holdings.

Number of Shares
753
Previous 753 -0.0%
Holding current value
$246,584
Previous $205,000 22.44%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $168,897 - $239,009
753 New
753 $230,000
Q4 2018

Feb 08, 2019

SELL
$220.1 - $309.0 $165,735 - $232,677
-753 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$244.1 - $303.88 $183,807 - $228,821
753 New
753 $217,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.07B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Beacon Investment Advisory Services, Inc. Portfolio

Follow Beacon Investment Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.